Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022)
Nephros (NEPH) posted quarterly Liabilities from Discontinued Operations of 130000.0 for Q3 2022, up 80.56% quarter-over-quarter from 72000.0 in Q4 2021.
Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022) Analysis & Trends
Nephros' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 130000.0 for Q3 2022.
- In Q3 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 130000.0; the TTM figure through Sep 2022 stood at 130000.0 (changed N/A YoY), while the FY2021 annual figure was 72000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q3 2022 stood at 130000.0, up from 72000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 130000.0 in Q3 2022, with the low at 72000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 130,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Dec 31, 2021 | 72,000.00 |